U.K. approves clinical trial of stem cell therapy from ReNeuron

01/18/2009 | Yahoo!

The U.K.'s Medicines and Healthcare products Regulatory Agency has allowed ReNeuron Group to start a Phase I clinical study of its stem cell treatment, which is designed to regenerate portions of the brain impaired by stroke. Called ReN001, the therapy is derived from cells from human fetal tissue and will be directly injected into the brains of 12 people between six and 24 months following their stroke.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN